Science
Mechanism of Action
This ingredient operates via two distinct pathways: it utilizes the trifluoroacetate group to break down desmosomal bonds for effective keratolysis, and it acts as an anti-angiogenic agent by inhibiting calcium entry into endothelial cells, thereby blocking Vascular Endothelial Growth Factor (VEGF) signaling to reduce unwanted neovascularization.
Research
Clinical Evidence
Medium confidence5%
Key findings
- 01 Demonstrated significant reduction in hyperkeratotic lesions and skin thickening at concentrations between 5-10%.
- 02 In-vitro evidence confirms the inhibition of endothelial growth factor signaling, suggesting efficacy for rosacea-prone skin.
- 03 Identified as effective for active skin benefits in hair and skin care at levels ranging from 0.25% to 2%.
Transparency
Dusting Analysis
While commercial products often include this at levels as low as 0.006%, therapeutic keratolytic benefits typically require concentrations above 0.25%, with optimal textural refinement appearing at much higher percentages (5%+).
The Formula
Formulation
Stability
Thermally sensitive; begins decomposition at 106°C. Must be formulated in aqueous environments and kept away from high-heat processing.
Synergies
- Low-pH surfactants
- Chelating agents
- Soothing anti-inflammatories
Conflicts
- High temperatures (>100°C)
- Strong bases
- Highly reactive nucleophiles
Safety
Safety Profile
Currently categorized by the FDA as a PFAS due to its fluorinated structure, leading to increased regulatory oversight. While generally well-tolerated topically, its long-term environmental and systemic profile is under scrutiny.
Your Skin
Skin Compatibility
Our Assessment
Verdict
While a potent dual-action exfoliant and anti-redness active, its classification as a PFAS and lack of extensive CIR safety data make it a controversial choice for modern precision skincare.
Related
Similar Ingredients
Finding similar ingredients…
References
Sources